COMPANY

Microgen LLC

HQ: La Marque, TX source · microgenlabs.com ↗ · Southwest

Location: La Marque, TX · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Mental Health Wellness 1 Preterm Birth

1Trials (company is sponsor)20NIH grants

Timeline

May 6, 2025 Grant Government grant — SBIR: $944,183 (annual award, as published), announced May 6, 2025. Agency: NIH/NIDCD. Source: government award database. source ↗
Aug 1, 2021 Trial start Not phased (device or behavioral study): Reducing Pregnancy Risks: The Mastery Lifestyle Intervention source ↗

Funding

Last 2 years.

May 6, 2025 Government grant — SBIR: $944,183 (annual award, as published), announced May 6, 2025. Agency: NIH/NIDCD. Source: government award database. source ↗

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT05012072	Reducing Pregnancy Risks: The Mastery Lifestyle Intervention	Not phased (device or behavioral study)	Recruiting	Aug 1, 2021	Mar 9, 2026 (estimated)

NIH awards 20

Annual award amounts. Total $6.4M.

Jul 5, 2024 NIH award 5R44DC019890-03 FY2024: $998,523 awarded for that fiscal year; activity R44 (SBIR); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, LA MARQUE, TX. Development of a High Throughput Assay for source ↗
Feb 23, 2024 NIH award 5R01HD101535-04 FY2024: $614,344 awarded for that fiscal year; activity R01 (OTHER_NIH); PI RUIZ, ROBERTA JEANNE; recipient as written: MICROGEN, LLC, LA MARQUE, TX. Reductions in biopsychosocial risks for source ↗
Aug 30, 2023 NIH award 1R43PS005273-01 FY2022: $299,801 awarded for that fiscal year; activity R43 (SBIR); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, LA MARQUE, TX. PA21259, SBIR, Phase I, Development of a Hi source ↗
Jun 30, 2023 NIH award 2R44DC019890-02 FY2023: $1,034,453 awarded for that fiscal year; activity R44 (SBIR); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, LA MARQUE, TX. Development of a High Throughput Assay fo source ↗
Feb 24, 2023 NIH award 5R01HD101535-03 FY2023: $627,249 awarded for that fiscal year; activity R01 (OTHER_NIH); PI RUIZ, ROBERTA JEANNE; recipient as written: MICROGEN, LLC, LA MARQUE, TX. Reductions in biopsychosocial risks for source ↗
Jun 13, 2022 NIH award 1R43DC019890-01 FY2022: $291,613 awarded for that fiscal year; activity R43 (SBIR); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, LA MARQUE, TX. Development of a High Throughput Assay for source ↗
Feb 25, 2022 NIH award 5R01HD101535-02 FY2022: $625,951 awarded for that fiscal year; activity R01 (OTHER_NIH); PI RUIZ, ROBERTA JEANNE; recipient as written: MICROGEN, LLC, LA MARQUE, TX. Reductions in biopsychosocial risks for source ↗
Dec 15, 2021 NIH award 5R03AI151426-02 FY2022: $89,515 awarded for that fiscal year; activity R03 (OTHER_NIH); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, LA MARQUE, TX. The Impact of Maternal CMV Infection on source ↗
Apr 7, 2021 NIH award 1R01HD101535-01A1 FY2021: $643,393 awarded for that fiscal year; activity R01 (OTHER_NIH); PI RUIZ, ROBERTA JEANNE; recipient as written: MICROGEN, LLC, LA MARQUE, TX. Reductions in biopsychosocial risks fo source ↗
Jan 21, 2021 NIH award 1R03AI151426-01A1 FY2021: $89,515 awarded for that fiscal year; activity R03 (OTHER_NIH); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, LA MARQUE, TX. The Impact of Maternal CMV Infection source ↗
May 11, 2020 NIH award 1R43AI152629-01 FY2020: $189,631 awarded for that fiscal year; activity R43 (SBIR); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, LA MARQUE, TX. Rapid User Friendly POC Diagnostic for HSV source ↗
May 15, 2019 NIH award 3R43AI134194-01S1 FY2019: $122,205 awarded for that fiscal year; activity R43 (SBIR); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, LA MARQUE, TX. Low Cost Point-Of-Care Test For CMV source ↗
May 9, 2019 NIH award 5R03AI135154-02 FY2019: $87,475 awarded for that fiscal year; activity R03 (OTHER_NIH); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, LA MARQUE, TX. Cytometric Enumeration of EBV-Infected source ↗
May 29, 2018 NIH award 1R03AI135154-01 FY2018: $87,475 awarded for that fiscal year; activity R03 (OTHER_NIH); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, LA MARQUE, TX. Cytometric Enumeration of EBV-Infected source ↗
Jul 12, 2017 NIH award 1R43AI134194-01 FY2017: $223,447 awarded for that fiscal year; activity R43 (SBIR); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, LA MARQUE, TX. Low Cost Point-Of-Care Test For CMV source ↗
Jun 16, 2011 NIH award 5R03AI083062-02 FY2011: $76,725 awarded for that fiscal year; activity R03 (OTHER_NIH); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, LA MARQUE, TX. 3-D Oral Mucosa Model for EBV Pathogene source ↗
Jul 6, 2010 NIH award 1R03AI083062-01A1 FY2010: $77,500 awarded for that fiscal year; activity R03 (OTHER_NIH); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, LA MARQUE, TX. 3-D Oral Mucosa Model for EBV Pathoge source ↗
Mar 18, 2010 NIH award 5R03AI081021-02 FY2010: $76,725 awarded for that fiscal year; activity R03 (OTHER_NIH); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, LA MARQUE, TX. Rapid FISH Detection of EBV-infected Ce source ↗
Mar 26, 2009 NIH award 1R03AI081021-01A1 FY2009: $77,500 awarded for that fiscal year; activity R03 (OTHER_NIH); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, LA MARQUE, TX. Rapid FISH Detection of EBV-infected source ↗
Jun 28, 2004 NIH award 7R03AG021247-02 FY2002: $32,363 awarded for that fiscal year; activity R03 (OTHER_NIH); PI STOWE, RAYMOND PRESTON; recipient as written: MICROGEN, LLC, La Marque, TX. Neuroimmune Modulation of Virus Immunit source ↗